Temasek and TPG-Backed Dr Agarwal's Healthcare Files for IPO with Rs 300 Crore Fresh Issue, 6.95 Crore Shares OFS

Dr Agarwal's Healthcare, supported by Temasek Holdings and TPG, is set to enter the capital markets, having filed preliminary IPO papers with the Securities and Exchange Board of India (SEBI) on September 27.

The initial public offering (IPO) will consist of a fresh issue of equity shares valued at Rs 300 crore by the company, alongside an offer-for-sale (OFS) of 6.95 crore equity shares by the promoters and existing investors. This strategic move aims to raise significant capital to support the company's growth and expansion plans.

The selling shareholders in the OFS include prominent figures such as Amar Agarwal, Athiya Agarwal, Adil Agarwal, Anosh Agarwal, Ashvin Agarwal, Dr Agarwal's Eye Institute, Farah Agarwal, and Urmila Agarwal. These promoters and stakeholders are set to offload a substantial portion of their equity through this offering.

Dr Agarwal's Healthcare, a leading provider of eye care services, aims to utilize the funds raised from the fresh issue to enhance its operations, expand its network, and invest in advanced technology to better serve its patients. The IPO marks a significant step in the company’s journey towards becoming a more prominent player in the healthcare sector.

With the backing of renowned investment firms Temasek Holdings and TPG, Dr Agarwal's Healthcare is well-positioned to attract strong interest from investors. The IPO is anticipated to generate substantial attention in the market, reflecting the growing investor confidence in the healthcare sector.

This fundraising initiative is expected to further solidify Dr Agarwal's Healthcare's position in the industry, enabling it to continue providing top-notch eye care services and expanding its reach across various regions.

Read more :

No related blogs available.